PATENT CLAIM ANALYSIS

Application Number: 15912438
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "468000"]

Abstract:
The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.

Claim (Index 9):
The controlled release oral dosage formulation of  claim 8 , wherein said tablet is a matrix tablet.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 90.0
- Lexical Diversity: 1.21622
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13498751', '11846896', '10269551', '14611372', '12706429']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7632555970782403
- 35 USC 102 Novelty (BERT): 0.5247488708307634
- Combined Prediction Score: 0.7394049244534926
- Mean Citation Score: 282.302014
- Max Citation Score: 312.4602
- Similarity Product: 183.85813932259083

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test